Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.34NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.34NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.34NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.459EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.459NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.459NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.459NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.459NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.117EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.117NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.117NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.117NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.117NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.381EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.381NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.381NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.381NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.381NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.237EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.237NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.237NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.237NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.237NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.382EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.382NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.382NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.382NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.382NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.395EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.395NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.395NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.395NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.395NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.37NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.37NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.37NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.61EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.61NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.61NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.61NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.40NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.40NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.40NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used